Earnings History Data for Fate Therapeutics, Inc. (FATE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Fate Therapeutics, Inc.

Fate Therapeutics, Inc. is a biopharmaceutical company. The company focused on the discovery and development of adult stem cell modulators to treat hematologic malignancies, lysosomal storage disorders and muscular dystrophies. Fate Therapeutics, Inc. is headquartered in San Diego, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
03-11-2022 AH 4:00 PM ET
(Nov 3)
FATE Fate Therapeutics, Inc. 2,040 -0.86 -0.93 -0.57 Fate Therapeutics GAAP EPS of -$0.86 beats by $0.04, revenue of $14.98M misses by $0.51M
[11/3/2022 4:04 PM]
19.77 0.32 
(1.62%)
20.06 0.61 
(3.14%)
17.10 - 66.56 1,780,678 1,320,000 18,486
03-08-2022 AH 4:00 PM ET
(Aug 3)
FATE Fate Therapeutics, Inc. 3,000 -0.79 -0.86 -0.58 Fate Therapeutics GAAP EPS of -$0.79 beats by $0.04, revenue of $18.55M beats by $5.99M
[8/3/2022 4:45 PM]
32.48 -0.33 
(-1.02%)
3.92 -0.40 
(-9.26%)
17.10 - 97.43 1,876,615 1,010,000 51,552
04-05-2022 AH 4:00 PM ET
(May 4)
FATE Fate Therapeutics 2,758 -0.68 -0.78 0.00 Fate Therapeutics GAAP EPS of -$0.68 beats by $0.11, revenue of $18.4M beats by $9.39M
[5/4/2022 4:05 PM]
27.04 -3.65 
(-11.89%)
29.50 -1.19 
(-3.88%)
26.82 - 97.43 1,738,730 1,290,000 18,853
28-02-2022 AH 4:00 PM ET
(Feb 28)
FATE Fate Therapeutics, Inc. 3,240 -0.72 -0.68 -0.38 Fate Therapeutics GAAP EPS of -$0.72 misses by $0.04, revenue of $17.07M beats by $5.52M
[2/28/2022 4:01 PM]
34.30 -0.25 
(-0.72%)
34.55 0.0 
(0.00%)
30.14 - 98.86 1,490,165 1,440,000 512,969
04-11-2021 AH 4:00 PM ET
(Nov 4)
FATE Fate Therapeutics, Inc. 5,500 -0.57 -0.58 -0.36 Fate Therapeutics EPS beats by $0.13, beats on revenue
[11/4/2021 4:06 PM]
61.38 1.74 
(2.91%)
59.47 -0.18 
(-0.30%)
47.20 - 121.16 832,641 1,070,000 937
04-08-2021 AH 4:00 PM ET
(Aug 4)
FATE Fate Therapeutics, Inc. 7,790 -0.58 -0.52 -0.35 Fate Therapeutics EPS misses by $0.05, beats on revenue
[8/4/2021 4:06 PM]
95.65 9.92 
(11.57%)
85.70 -0.03 
(-0.03%)
29.37 - 121.16 1,079,142 740,000 180
05-05-2021 AH 4:00 PM ET
(May 5)
FATE Fate Therapeutics, Inc. 8,210 -0.48 -0.42 -0.44 Fate Therapeutics EPS misses by $0.05, beats on revenue
[5/5/2021 4:04 PM]
76.55 -1.18 
(-1.52%)
76.55 0.0 
(0.00%)
25.60 - 121.16 1,855,622 870,000 6,536
24-02-2021 AH 4:00 PM ET
(Feb 24)
FATE Fate Therapeutics, Inc. 10,180 -0.38 -0.38 -0.37 Fate Therapeutics EPS misses by $0.22, beats on revenue
[2/24/2021 4:05 PM]
86.22 -9.05 
(-9.50%)
99.91 4.64 
(4.87%)
16.75 - 121.16 1,143,872 960,097 3,845
05-11-2020 AH 4:00 PM ET
(Nov 5)
FATE Fate Therapeutics, Inc. 3,960 -0.36 -0.29 -0.40 Fate Therapeutics EPS misses by $0.36, beats on revenue
[11/5/2020 4:40 PM]
48.15 -1.77 
(-3.55%)
50.25 0.33 
(0.66%)
12.59 - 51.45 479,132 624,716 1,641
05-08-2020 AH 4:00 PM ET
(Aug 5)
FATE Fate Therapeutics, Inc. 2,710 -0.35 -0.20 -0.36 Fate Therapeutics EPS misses by $0.10, misses on revenue
[8/5/2020 4:02 PM]
33.68 0.84 
(2.57%)
32.00 -0.84 
(-2.56%)
12.59 - 38.52 511,072 565,345 230